Titre : Viscosité

Viscosité : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C3
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Viscosité : Questions médicales les plus fréquentes", "headline": "Viscosité : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Viscosité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-05", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Viscosité" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes chimiques", "url": "https://questionsmedicales.fr/mesh/D055598", "about": { "@type": "MedicalCondition", "name": "Phénomènes chimiques", "code": { "@type": "MedicalCode", "code": "D055598", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02" } } }, "about": { "@type": "MedicalCondition", "name": "Viscosité", "alternateName": "Viscosity", "code": { "@type": "MedicalCode", "code": "D014783", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Gregory D Sloop", "url": "https://questionsmedicales.fr/author/Gregory%20D%20Sloop", "affiliation": { "@type": "Organization", "name": "Pathology, Idaho College of Osteopathic Medicine, Meridian, USA." } }, { "@type": "Person", "name": "Gheorghe Pop", "url": "https://questionsmedicales.fr/author/Gheorghe%20Pop", "affiliation": { "@type": "Organization", "name": "Cardiology, Radboud University Medical Center, Nijmegen, NLD." } }, { "@type": "Person", "name": "Joseph J Weidman", "url": "https://questionsmedicales.fr/author/Joseph%20J%20Weidman", "affiliation": { "@type": "Organization", "name": "Internal Medicine, Independent Researcher, Columbia, USA." } }, { "@type": "Person", "name": "John A St Cyr", "url": "https://questionsmedicales.fr/author/John%20A%20St%20Cyr", "affiliation": { "@type": "Organization", "name": "Cardiac/Thoracic/Vascular Surgery, Jacqmar, Inc., Minneapolis, USA." } }, { "@type": "Person", "name": "Nguyen Ngoc Minh", "url": "https://questionsmedicales.fr/author/Nguyen%20Ngoc%20Minh", "affiliation": { "@type": "Organization", "name": "Department of Mechanical Systems Engineering, Tokyo Metropolitan University, Hachioji, Tokyo, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors: The Maastricht Study.", "datePublished": "2022-07-25", "url": "https://questionsmedicales.fr/article/35881455", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/HJH.0000000000003237" } }, { "@type": "ScholarlyArticle", "name": "Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.", "datePublished": "2023-04-27", "url": "https://questionsmedicales.fr/article/37105991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-37988-7" } }, { "@type": "ScholarlyArticle", "name": "Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.", "datePublished": "2023-07-14", "url": "https://questionsmedicales.fr/article/37453328", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cyto.2023.156295" } }, { "@type": "ScholarlyArticle", "name": "A novel fasting regimen revealed protein reservation and complement C3 down-regulation after 14-day's continual dietary deprivation.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37484967", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1150547" } }, { "@type": "ScholarlyArticle", "name": "Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36805858", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.imbio.2023.152351" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Viscosité", "item": "https://questionsmedicales.fr/mesh/D014783" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Viscosité - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Viscosité", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Viscosité", "description": "Comment évaluer la viscosité sanguine ?\nQuels tests diagnostiques sont utilisés ?\nQuels symptômes indiquent une viscosité élevée ?\nLa viscosité peut-elle être mesurée à domicile ?\nQuel rôle joue la viscosité dans les maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Viscosité", "description": "Quels symptômes sont liés à une viscosité sanguine élevée ?\nLa viscosité affecte-t-elle la circulation ?\nQuels signes indiquent une viscosité anormale ?\nLa viscosité peut-elle causer des douleurs articulaires ?\nQuels symptômes neurologiques peuvent apparaître ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Viscosité", "description": "Comment prévenir une viscosité sanguine élevée ?\nLe tabagisme influence-t-il la viscosité ?\nL'alcool affecte-t-il la viscosité ?\nLe stress a-t-il un impact sur la viscosité ?\nLes examens réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Viscosité", "description": "Comment traiter une viscosité sanguine élevée ?\nLes médicaments peuvent-ils réduire la viscosité ?\nQuel rôle joue l'hydratation dans le traitement ?\nLes changements alimentaires sont-ils efficaces ?\nQuand faut-il envisager une transfusion sanguine ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Viscosité", "description": "Quelles complications peuvent résulter d'une viscosité élevée ?\nLa viscosité peut-elle causer des problèmes respiratoires ?\nQuels risques pour les femmes enceintes ?\nLes personnes âgées sont-elles plus à risque ?\nComment la viscosité affecte-t-elle la cicatrisation ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Viscosité", "description": "Quels facteurs augmentent la viscosité sanguine ?\nL'âge influence-t-il la viscosité ?\nLe manque d'exercice est-il un facteur de risque ?\nLes maladies chroniques influencent-elles la viscosité ?\nLe régime alimentaire joue-t-il un rôle ?", "url": "https://questionsmedicales.fr/mesh/D014783?mesh_terms=Complement+C3&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la viscosité sanguine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La viscosité sanguine est mesurée par des tests de laboratoire, comme la viscosité capillaire." } }, { "@type": "Question", "name": "Quels tests diagnostiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'hématocrite et la protéine C-réactive aident à évaluer la viscosité." } }, { "@type": "Question", "name": "Quels symptômes indiquent une viscosité élevée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs thoraciques ou des troubles de la circulation peuvent indiquer une viscosité élevée." } }, { "@type": "Question", "name": "La viscosité peut-elle être mesurée à domicile ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, la mesure de la viscosité nécessite des équipements de laboratoire spécialisés." } }, { "@type": "Question", "name": "Quel rôle joue la viscosité dans les maladies cardiovasculaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une viscosité sanguine élevée peut augmenter le risque de thrombose et d'accidents vasculaires." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une viscosité sanguine élevée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, maux de tête, vertiges et troubles de la vision peuvent survenir." } }, { "@type": "Question", "name": "La viscosité affecte-t-elle la circulation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une viscosité élevée peut ralentir la circulation sanguine et provoquer des douleurs." } }, { "@type": "Question", "name": "Quels signes indiquent une viscosité anormale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements excessifs ou des ecchymoses fréquentes peuvent indiquer une viscosité anormale." } }, { "@type": "Question", "name": "La viscosité peut-elle causer des douleurs articulaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une viscosité élevée peut entraîner des douleurs articulaires dues à une circulation réduite." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la mémoire ou des difficultés de concentration peuvent survenir avec une viscosité élevée." } }, { "@type": "Question", "name": "Comment prévenir une viscosité sanguine élevée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hydratation, une alimentation équilibrée et faire de l'exercice régulièrement." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la viscosité ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter la viscosité sanguine et le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "L'alcool affecte-t-il la viscosité ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive d'alcool peut augmenter la viscosité sanguine et nuire à la santé." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la viscosité ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la viscosité sanguine en augmentant la pression artérielle." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter des problèmes de viscosité avant qu'ils ne s'aggravent." } }, { "@type": "Question", "name": "Comment traiter une viscosité sanguine élevée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des anticoagulants, des modifications alimentaires et une hydratation adéquate." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire la viscosité ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme l'aspirine peuvent aider à réduire la viscosité sanguine." } }, { "@type": "Question", "name": "Quel rôle joue l'hydratation dans le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hydratation peut fluidifier le sang et réduire la viscosité, améliorant la circulation." } }, { "@type": "Question", "name": "Les changements alimentaires sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en oméga-3 et en antioxydants peut aider à réduire la viscosité." } }, { "@type": "Question", "name": "Quand faut-il envisager une transfusion sanguine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une transfusion peut être nécessaire en cas de viscosité extrême entraînant des complications graves." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une viscosité élevée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des thromboses, des AVC et des problèmes cardiaques peuvent survenir." } }, { "@type": "Question", "name": "La viscosité peut-elle causer des problèmes respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une viscosité élevée peut entraîner des embolies pulmonaires, affectant la respiration." } }, { "@type": "Question", "name": "Quels risques pour les femmes enceintes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une viscosité sanguine élevée peut augmenter le risque de complications pendant la grossesse." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de viscosité élevée et de complications associées." } }, { "@type": "Question", "name": "Comment la viscosité affecte-t-elle la cicatrisation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une viscosité élevée peut ralentir la cicatrisation des plaies en réduisant l'apport sanguin." } }, { "@type": "Question", "name": "Quels facteurs augmentent la viscosité sanguine ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le diabète, et l'hyperlipidémie sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "L'âge influence-t-il la viscosité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter la viscosité sanguine en raison de changements physiologiques." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut contribuer à une viscosité sanguine élevée." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles la viscosité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'hypertension et les maladies rénales peuvent augmenter la viscosité." } }, { "@type": "Question", "name": "Le régime alimentaire joue-t-il un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées et en sucres peut augmenter la viscosité sanguine." } } ] } ] }

Sources (1987 au total)

Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors: The Maastricht Study.

Arterial stiffness predicts cardiovascular outcomes. The complement system, particularly the alternative complement pathway, has been implicated in cardiovascular diseases. We herein investigated the ... In 3019 population-based participants (51.9% men, 60.1 ± 8.2 years, 27.7% type 2 diabetes [T2D], oversampled]), we measured carotid-femoral pulse wave velocity (cfPWV), carotid distensibility coeffici... Per SD higher factors D and C3, cfPWV was 0.41 m/s [95% confidence interval: 0.34; 0.49] and 0.33 m/s [0.25; 0.41] greater, respectively. These associations were substantially attenuated when adjusted... The strong association of plasma factors D and C3 with arterial stiffness in this population-based cohort was not independent of T2D and other metabolic risk factors. Our data suggest that a possible ...

Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.

African Trypanosomes have developed elaborate mechanisms to escape the adaptive immune response, but little is known about complement evasion particularly at the early stage of infection. Here we show...

Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.

Biological markers associated to post-COVID-19 condition (PCC) have not been clearly identified.... Eighty-two patients attending our post-COVID-19 outpatient clinic were recruited and classified as fully recovered (40.2%) or presenting with PCC (59.8%). Clinical and radiological data, laboratory ma... Median number of days after hospitalization was 78.5 [p25-p75: 60-93] days. PCC was significantly more frequent in women, in patients with a previously critical COVID-19, and in those with two or more... Patients with a post-COVID-19 condition showed significantly increased immunological parameters of inflammation (complement factor C3 and CD8 and Th1 T lymphocyte populations) compared to fully recove...

A novel fasting regimen revealed protein reservation and complement C3 down-regulation after 14-day's continual dietary deprivation.

The aim is to evaluate the effect of a novel 14-day fasting regimen on the balance between skeletal muscle and adipose tissue composition which might associate with inflammatory factors. Our analysis ... Eight healthy subjects were randomly selected from a pool of volunteers to undergo a continual dietary deprivation (CDD) regimen. Individuals were assigned to take Flexible Abrosia (FA, prebiotic comb... The combination of FA and mineral supplements significantly decreased self-reported physical response of starvation, with tolerable hunger-mediated sensations experienced during CDD. Bioelectrical and... Our results indicated that human subjects undergoing prolonged dietary restriction were well protected by FA and mineral ions from gut injury or physical discomfort of starvation. Most factors showed ...

Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis.

Patients with chronic hepatitis B (CHB) have a dynamic disease process and risk of end-stage liver disease. It is critical to unambiguously differentiate the stages of the disease and focus on therapy... We retrospectively analyzed a wide range of CHB patients at different stages. The predictive power of serum complement component 3 (C3) levels for the development of acute-on-chronic liver failure (AC... The decrease in serum C3 levels paralleled the severity of diseases related to hepatitis B virus. Patients with decompensated cirrhosis who developed ACLF had significantly lower serum C3 levels than ... Serum C3 levels are valuable in assessing the severity of CHB-related stages. Low C3 levels signifies the development of ACLF in patients with decompensated cirrhosis....

Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan.

C3 glomerulopathy (C3G) is a rare, progressive kidney disease resulting from dysregulation of the alternative pathway (AP) of complement. Biomarkers at baseline were investigated in patients with C3G ... Patients with biopsy-confirmed C3G, proteinuria ≥500 mg/day, and estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 were enrolled into two studies (NCT03369236 and NCT03459443). Biomarker ... Twenty-nine patients were included in the analysis (median [interquartile range] age: 24.0 [10.0] years). Systemic complement AP activation was evident by reduced median concentrations of C3 and C5, e... Associations among complement biomarkers, kidney function, and kidney histology may add to the current understanding of C3G and assist with the characterization of patients with this heterogenous dise...

Complement component C3 and C5b-9 deposition on hypoxia reperfused endothelial cells by non-HLA antibodies against RhoGDI2: A player involved in graft failure?

Antibodies against Rho GDP-dissociation inhibitor 2 (RhoGDI2) are associated with inferior graft survival in transplant patients receiving a kidney from deceased donors. Although this suggests that th...